article · International Journal of Research and Innovation in Applied Science
This study investigated the potential of expired Lopinavir-Ritonavir (LPV-RTV) co-formulated antiretroviral drug, a pharmaceutical waste product, as a corrosion inhibitor for mild steel. The corrosion inhibition efficiency of expired LPV-RTV was evaluated through three complementary methods: weight loss, potentiodynamic polarization (PDP), and Scanning Electron Microscopy with Energy Dispersive X-ray Spectroscopy (SEM-EDX). The results demonstrated that expired LPV-RTV significantly enhanced the corrosion resistance of mild steel, achieving maximum inhibition efficiencies of 95.7% by weight loss and 93.0% by PDP. SEM-EDX analysis of the steel surfaces revealed the formation of a protective layer, further supporting the corrosion inhibition mechanism. These findings highlight the effectiveness of expired LPV-RTV as an efficient, eco-friendly corrosion inhibitor. The study also emphasizes the potential of utilizing expired pharmaceuticals for sustainable resource recovery, offering a viable solution for both pharmaceutical waste reduction and industrial corrosion control.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.51584/ijrias.2026.11030045
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
